DUBLIN--(BUSINESS WIRE)--The "Global Platelet Aggregation Devices Market - Segmented by Product (Systems, Reagents, Consumables and Accessories), Application, End User and Geography - Growth, Trends ...

Aspirin is widely prescribed for the secondary prevention of ischemic stroke and acute coronary syndromes, but some patients do not respond to this therapy. There is evidence that these ...

March 6, 2009 (Munich, Germany) — More evidence that patients with a low platelet responsiveness to clopidogrel have an increased risk of stent thrombosis has come from a new study, with the ...

A new study created a score to identify patients with platelet hyperreactivity and risk of related, future cardiovascular disease. Platelets are circulating cell fragments known to clump up and form ...

Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels. Cardiologists have long known that platelets can become "hyperreactive" to cause ...

A novel score of platelet reactivity expression appears promising for detecting hyperreactivity in patients at increased risk for cardiovascular events, potentially allowing clinicians to better ...

Please provide your email address to receive an email when new articles are posted on . Published data did not support the theory that rebounding blood platelets account for clusters of thrombotic ...

April 10, 2009 (Munich, Germany) — A new study using platelet-aggregometry testing to assess the effects of different proton-pump inhibitors (PPIs) on platelet response to clopidogrel suggests that ...

The global Platelet Aggregation Devices Market is valued at USD 590.65 Million in 2024 and is projected to reach a value of USD 1086 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 5.75% ...

Background Long-term success in ventricular assist device (VAD) recipients is limited by thromboembolic events, the prediction of which remains elusive. We evaluated the predictive value of aspirin ...

Even relatively mild anemia predicts high residual platelet reactivity following percutaneous coronary intervention (PCI) in patients pre-treated with clopidogrel, according to data published online ...

Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels. Cardiologists have long known that platelets can become “hyperreactive” to cause ...